+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid combined with norfloxacin prevented polyethylene stent occlusion A randomized trial



Ursodeoxycholic acid combined with norfloxacin prevented polyethylene stent occlusion A randomized trial



Journal of Hepatology 21(Suppl. 1): S87




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144802

Download citation: RISBibTeXText

DOI: 10.1016/s0168-8278(05)80987-0


Related references

Randomized trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Gastrointestinal Endoscopy 42(1): 103-104, 1995

Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial. Digestive Diseases and Sciences 45(1): 145-150, 2000

Prevention of polyethylene stent occlusion by norfloxacine and ursodeoxycholic acid A randomized multicenter trial. Journal of Hepatology 26(Suppl. 1): 300, 1997

Ursodesoxycholic acid combined with norfloxacine prevented polyethylene stent occlusion Result of a randomized study. Gastroenterology 106(4 Suppl. ): A334, 1994

Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Lancet (North American Edition) 344(8922): 581-582, 1994

Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. Endoscopy 33(6): 491-494, 2001

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 24(5): 1098-1103, 1996

The Italian multi-centre randomized controlled trial of ursodeoxycholic acid vs ursodeoxycholic acid plus colchicine in symptomatic primary biliary cirrhosis. Hepatology 20(4 Part 2): 267A, 1994

Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: Controlled randomized trial in 203 patients. Digestive & Liver Disease 32(1): 29-33, January-February, 2000

Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients. European Journal of Gastroenterology and Hepatology 11(10): 1077-1083, 1999

Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients. Hepatology 21(2): 322-327, 1995

Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. Cochrane Database of Systematic Reviews 2002(3): Cd003043, 2002

Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. Gut 35(12): 1757-1759, 1994